Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies

BACKGROUND: Risk of invasive pneumococcal disease is 3-fold higher in preterm versus full-term infants. V114 is a 15-valent pneumococcal conjugate vaccine (PCV) containing the 13 serotypes in PCV13 plus 2 unique serotypes, 22F and 33F. A pooled subgroup analysis was performed in preterm infants (<...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Timothy J., Patel, Shrita M., Flores, Sheryl A., Xu, Shengjie, Lupinacci, Robert, Shi, Yaru, Shekar, Tulin, Feemster, Kristen, Yi, Jumi, Tamms, Gretchen, Kaminski, Janusz, Bickham, Kara, Musey, Luwy, Buchwald, Ulrike K., Banniettis, Natalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Vaccine Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569678/
https://www.ncbi.nlm.nih.gov/pubmed/37566897
http://dx.doi.org/10.1097/INF.0000000000004069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569678/
https://www.ncbi.nlm.nih.gov/pubmed/37566897
http://dx.doi.org/10.1097/INF.0000000000004069

Ejemplares similares